-+ 0.00%
-+ 0.00%
-+ 0.00%

HiCisco (002653.SZ): Enrikofen injection was added to the national health insurance catalogue

Zhitongcaijing·12/08/2025 03:57:02
Listen to the news

<国家基本医疗保险、生育保险和工伤保险药品目录><商业健康保险创新药品目录>Zhitong Finance App News, HiCisco (002653.SZ) issued an announcement. The National Health Insurance Administration and the Ministry of Human Resources and Social Security issued the “Notice Concerning Issuance and> (“National Health Insurance Catalogue (2025 Edition)”) (Health Insurance Distribution (2025) No. 33) on December 7, 2025. The company successfully renewed its contract for cyclopofol injections, and Enrikofen injections were added to the “National Medical Insurance Catalogue (2025 Edition)”.

Enrikofen injection is a highly selective peripheral kappa opioid receptor (KOR) agonist independently developed by the company. It is also the first white-prescription opioid analgesic drug in the world to obtain analgesic indications without being included in the management of narcotic drugs. The company currently has four Class 1 innovative drugs, including cyclopofol injections, enrexifene injections, cligabarin benzenesulfonate capsules, and coglitin tablets, included in the national medical insurance catalogue (2025 edition).